As conversations around inclusivity continue to shape the aesthetics industry, one area receiving long-overdue attention is the treatment of melanin-rich skin. While demand for aesthetic procedures has grown significantly across diverse communities, gaps in education, research, and tailored treatment protocols still remain.
Bridging this gap is not simply about expanding treatment menus — it is about improving understanding, safety, and representation within clinical practice.
Melanin-rich skin presents unique characteristics that require specific clinical consideration. Increased melanin levels can influence how skin responds to energy-based devices, chemical peels, and certain injectables. Without proper training and experience, there is a higher risk of complications such as post-inflammatory hyperpigmentation, scarring, or uneven results.
Historically, much of the research and product development within aesthetics has centred on lighter skin types. As a result, practitioners have often needed to adapt existing protocols rather than work from evidence specifically designed for darker skin tones.
Industry leaders and progressive clinics are increasingly advocating for:
Expanded practitioner education focused on Fitzpatrick IV–VI skin types
Greater diversity in clinical trials and product testing
Open conversations about cultural considerations and patient expectations
Safer device settings and tailored treatment plans
This shift reflects a broader cultural movement — one that recognises that aesthetic medicine must serve all communities with equal expertise and care.
Technology is evolving, and many modern devices now offer more adaptable settings, improved cooling systems, and safer energy delivery for darker skin tones. However, technology alone is not enough. Practitioner knowledge, patient communication, and realistic treatment planning remain central to successful outcomes.
Clinics that prioritise inclusivity are not only improving patient safety but also building stronger trust within their communities. Patients are increasingly seeking practitioners who demonstrate an understanding of their specific skin needs rather than applying a one-size-fits-all approach.
Addressing melanin-rich skin aesthetics is also part of a larger conversation around identity, confidence, and representation. Skin health is deeply personal, and patients want to feel seen, understood, and supported throughout their aesthetic journey.
By bridging educational gaps, improving representation in research, and prioritising tailored care, the industry can move closer to truly inclusive aesthetics — where every skin tone receives expert-led, evidence-based treatment.
We’d like to extend our sincere thanks to the author for contributing such an important and timely piece on melanin-rich skin aesthetics. Conversations like this are essential in moving the industry forward and ensuring more inclusive, informed, and culturally aware practice across aesthetics.
For more information about The Aesthetic Clinic UK and their work, please visit: https://tac.aestheticclinicgroup.com/